Tegafur

Determination of tegafur and uracil in composite preparations by UV simultaneous equations method

喃氟啶和尿嘧啶复方制剂的紫外分光解线性方程法测定

Studies on kinetics of hydrolysis of tegafur

喃氟啶水解动力学的研究

Study on small intestinal absorption of tegafur new proliposome in rat

替加氟新型前体脂质体小肠吸收试验研究

The Safety Assessment of Tegafur Injection Combined with Chemotherapy for Digestive System Cancers

替加氟注射液联合化疗治疗消化道肿瘤安全性评价

Determination of tegafur in oral emulsion by second order derivative UV Spectrophotometry

替加氟口服乳剂的二阶导数分光光度测定

Tegafur Combined with Late Course Accelerated hyperfractionation Radiotherapy for Advanced Esophageal Cancer

替加氟增敏并后程加速超分割放射治疗食管癌

Docetaxel Combined with Cisplatin and Tegafur in Treatment of Advanced Gastric Carcinoma

多西他赛联合顺铂和替加氟治疗进展期胃癌的临床分析

Clinical observation of combined chemotherapy of tegafur and oxaliplatin for treatment of advanced gastric cancer

替加氟联合奥沙利铂方案治疗晚期胃癌的疗效观察

HPLC determination of Fluorouracil and related substances in Tegafur Injection

HPLC法测定替加氟注射液中的氟尿嘧啶等有关物质

Study of antitumor activity of conjugate of phospholipid with tegafur

磷脂替加氟缀合物抑瘤作用的研究

Identification of Tegafur and Its Tablets by IR Spectrum

替加氟及其片剂的红外光谱鉴别

Method On the base of the single factor investigation , preparation conditions of tegafur liposome were optimized by uniform design .

方法在单因素考察的基础上，采用均匀设计法进行优化实验。

Clinical Effects of Radiotherapy Combined with Tegafur Suppository Treatment for Mid-to Late-Stage Esophageal Cancer

放疗联合替加氟栓同步治疗中晚期食管癌的临床研究

Pharmacokinetics and liver targeting of tegafur magnetic long-circulating liposomes in rats

替加氟磁性长循环脂质体在大鼠体内的药代动力学和靶向性

Influence of survival rate on postoperative tegafur adjuvant chemotherapy in patients with squamous cell carcinoma undergoing Ro resection

术后替加氟辅助化疗对Ro切除的食管鳞癌患者生存率的影响

Content determination of Tegafur in Tegafur Capsules by HPLC

高效液相色谱法测定替加氟胶囊中替加氟的含量

A Study of Concurrent Versus Sequential Chemoradiotherapy with Tegafur and Cisplatin for Old Patients with Locally Advanced Esophageal Carcinoma

放疗联合方克顺铂同步或序贯化疗治疗老年晚期食管癌的临床研究

Observation of curative effect of OXA united with Tegafur and Calcium Leucovorin for curing gastric and intestinal cancer

草酸铂联合替加氟及甲酰四氢叶酸钙治疗胃肠肿瘤的疗效观察

Efficacy comparison of tegafur or fluorouracil combined with oxaliplatin and calcium folinate to treat patients with advanced gastric cancer

草酸铂及亚叶酸钙分别联合替加氟或氟尿嘧啶治疗晚期胃癌疗效比较

An UV simultaneous equations method has been developed for determination of tegafur and uracil in composite preparations using neutral buffer solution .

在中性缓冲溶液中，用紫外分光解线性方程法，直接同时测定复方胶囊中喃氟啶（1）和尿嘧啶（2）的含量。

In order to search novel 5-fluorouracil derivative antitumor drugs , we designed and synthesized 20 novel tegafur containing phosphorus compounds .

为了寻找新型的5-氟尿嘧啶类药物，本文以替加氟为原料设计合成了20种未见文献报道的含磷（膦）酸酯的替加氟的衍生物。

Tegafur and gecko decoction could depress in value of esophageal cancer rates , but the difference was not statistically significant .

替加氟及壁虎水煎液均可在数值上降低食管癌变率，但差异无统计学意义；

Tegafur is a broad spectrum anticancer drugs , it is mainly used in the treatment of gastric cancer , colorectal cancer and so on .

替加氟是一种广谱性的抗肿瘤药物，主要用于治疗胃癌、结直肠癌等。

Conclusion : The results indicated that T-LPO could alter the tegafur distribution in the colon of rats and have the tendency of colon-targeting .

结论：替加氟脂质体改变了药物在结肠中的分布，具有一定的结肠靶向性。

The tumor control rate both of Chinese medicinal formulae group and Tegafur group were higher than 30 % , and there were no significant deviation between them ( P > 0.05 ) .

中药组方组和替加氟组的抑瘤率均大于30%；中药组方组与替加氟组的抑瘤率无显著性差异（P>0.05）。

The Research on the Synthesis of Diselenides 、 Tegafur Diselenides and Organoselenium Sugars by the Catalysis of Cesium Ion

铯离子催化下二硒醚、替加氟二硒醚及有机硒糖的合成研究

CONCLUSION The simulated concentration-time curves of tegafur and its metabolite in plasma and tissue basically describe the activation process of tegafur into 5-FU and 5-FU elimination .

结论血浆、乳腺肿瘤组织和相邻正常组织的药-时曲线拟合对替加氟转化为5-FU及5-FU消除过程进行了较好的描述。

Results The mean quality of tumor in either of Chinese medicinal formulae group and Tegafur group was light than the normal saline group , and there was significant deviation between them ( P < 0.01 ) .

结果中药组方组和替加氟组小鼠皮下肿瘤平均质量均比生理盐水组小，有显著性差异（P均<0.01）；

Objective To determine the maximum-tolerated dose ( MTD ) and dose-limiting toxicity ( DLT ) of tegafur and oxaliplatin in patients with gastrointestinal cancers .

目的探索不同剂量方克（替加氟）联合草酸铂治疗胃肠道癌的最大耐受剂量（MTD）和剂量限制性毒性（DLT）。

Objective : 1 . To observe the effectiveness and safety of a combination therapy of S-1 and Oxaliplatin in the treatment of advanced gastric cancer , compared with a chemotherapy regimen of tegafur and Oxaliplatin .

目的：1.比较复方替加氟奥替拉西胶囊（S-1）加草酸铂与替加氟加草酸铂治疗晚期胃癌的近期疗效、毒副反应、临床获益反应和疾病进展时间、生存期。